Get started
Author

Daniela Ghidetti Mangas Catarino

Observed names: Catarino, Daniela Ghidetti Mangas, Catarino, Daniela Ghidetti Mangas [UNIFESP], Daniela G M Catarino, Daniela G.M. Catarino
Observed institution: Hospital Alemão Oswaldo Cruz
OpenAlex ID: A5017465007
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial
2022 · Álvaro Avezum, Gustavo B F Oliveira, et al. · The Lancet Regional Health - Americas · 53
PDF
IMPACTO-MR: um estudo brasileiro de plataforma nacional para avaliar infecções e multirresistência em unidades de terapia intensiva
2022 · Bruno M. Tomazini, Antonio Paulo Nassar Júnior, et al. · Revista Brasileira de Terapia Intensiva · 14
IMPACTO-MR: a Brazilian nationwide platform study to assess infections and multidrug resistance in intensive care units
2022 · Bruno M. Tomazini, Antonio Paulo Nassar Júnior, et al. · Revista Brasileira de Terapia Intensiva · 13
Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study
2023 · Beatriz Arns, Crepin Aziz Jose Oluwafoumi Agani, et al. · Antimicrobial Stewardship & Healthcare Epidemiology · 7
PDF
Application of ventilator-associated events (VAE) in ventilator-associated pneumonia (VAP) notified in Brazil (IMPACTO MR-PAV): a protocol for a cohort study
2023 · Giovanna Marssola Nascimento, Daniela Laranja Gomes Rodrigues, et al. · BMJ Open · 4
PDF
Rivaroxabana em Pacientes Ambulatoriais com COVID-19 Leve ou Moderada: Fundamentação e Desenho do Estudo CARE (CARE – Coalition COVID-19 Brazil VIII)
2023 · Gustavo B. F. Oliveira, Precil Diego M. M. Neves, et al. · Arquivos Brasileiros de Cardiologia · 2
PDF
Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE – Coalition COVID-19 Brazil VIII)
2023 · Oliveira, Gustavo B. F., Neves, Precil Diego M. M., et al. · Figshare · 1
Assessment of complement activation in SARS-CoV-2 (COVID-19) infection with D-dimer greater than 3,000 ng/mL FEU
2025 · Catarino, Daniela Ghidetti Mangas [UNIFESP] · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study – CORRIGENDUM
2023 · Beatriz Arns, Crepin Aziz Jose Oluwafoumi Agani, et al. · Antimicrobial Stewardship & Healthcare Epidemiology
PDF
Works count: 9
Citation count: 94
H-index: 4
I10-index: 3
Year
Topic
Type